Skip to main content

Home/ Health Now/ Group items tagged medical journals

Rss Feed Group items tagged

avivajazz  jazzaviva

Webicina.com * PeRSSonalized Medicine - 0 views

  •  
    PeRSSonalized Medicine is a free tool that lets you select your favourite resources and read the latest news and articles in one personalized place. You can create your own "medical journal" and as we are totally open to suggestions, let us add the journals, blogs and websites that you would like to follow. You can use it for free and without registering on Webicina. But if you're a registered user, your settings will certainly be saved properly. Read more about the details on the Webicina Blog.
Dr. John Bureau DC

Swine Flu: Influenza A (H1N1) Susceptibility Linked To Common Levels Of Arsenic Exposure - 0 views

  • ScienceDaily (May 21, 2009) — The ability to mount an immune response to influenza A (H1N1) infection is significantly compromised by a low level of arsenic exposure that commonly occurs through drinking contaminated well water, scientists at the Marine Biological Laboratory (MBL) and Dartmouth Medical School have found. See also: Health & Medicine Immune System Swine Flu Influenza Earth & Climate Hazardous Waste Water Environmental Issues Reference Flu vaccine Pandemic Heat shock protein Avian flu Joshua Hamilton, the MBL's Chief Academic and Scientific Officer and a senior scientist in the MBL's Bay Paul Center; graduate student Courtney Kozul of Dartmouth Medical School, where the work was conducted; and their colleagues report their findings in the journal Environmental Health Perspectives.
  •  
    for more articles see blog drjohndc.tumblr.com
  •  
    ScienceDaily (May 21, 2009) - The ability to mount an immune response to influenza A (H1N1) infection is significantly compromised by a low level of arsenic exposure that commonly occurs through drinking contaminated well water, scientists at the Marine Biological Laboratory (MBL) and Dartmouth Medical School have found. Joshua Hamilton, the MBL's Chief Academic and Scientific Officer and a senior scientist in the MBL's Bay Paul Center; graduate student Courtney Kozul of Dartmouth Medical School, where the work was conducted; and their colleagues report their findings in the journal Environmental Health Perspectives.
avivajazz  jazzaviva

Free Medical Journals - 0 views

  •  
    Professional medical journals that provide full text articles or entirely open access to non-subscribers.
Dr. John Bureau DC

Taking Folic Acid Supplements Before Conception Linked To Reduced Risk Of Premature Birth - 0 views

  •  
    ScienceDaily (May 12, 2009) - Taking folic acid supplements for at least a year before conception is associated with reduction in the risk of premature birth, according to a study by Radek Bukowski (from the University of Texas Medical Branch, United States of America) and colleagues. Although most pregnancies last about 40 weeks, many babies (for example around 12% in the United States) are born before 37 completed weeks of pregnancy. Babies born prematurely are less likely to survive than full-term babies and are more likely to have breathing difficulties and learning or developmental disabilities. Currently, there are no effective methods of prevention or treatment of premature (preterm) birth, but previous studies have suggested that lower concentrations of folate (folic acid) are associated with shorter duration of pregnancy. Bukowski and colleagues therefore tested this idea, by analyzing data collected from a cohort of nearly 35,000 pregnant women. The results of this study showed that taking folate supplements for at least one year before conception was associated with a 70% reduction in spontaneous premature birth between 20 and 28 weeks (a reduction from 0.27% to 0.04%), and a 50% reduction between 28 and 32 weeks (reduction from 0.38% to 0.18%), as compared to the rate of preterm birth when mothers did not take additional folate supplementation. Folate supplementation for less than a year before conception was not linked to a reduction in the risk of premature birth in this study, and folate supplementation was not associated with any other complications of pregnancy. In a related commentary also published in this week's PLoS Medicine, Nicholas Fisk from the University of Brisbane, Australia, and colleagues (who were not involved in the original study) say "Methodologically, the study has several strengths... It is based on a huge dataset, with prospective recording of dietary supplements and potential confounders, and gestational age determined accu
Dr. John Bureau DC

Folic acid may boost baby's heart health: Study - 0 views

  • Increased intakes of folic acid by mandatory fortification of grain products to reduce neural tube defects may also reduce a baby’s risk of severe congenital heart defects, says a new study. The incidence of the heart problems was reduced by 6 per cent following mandatory fortification of grain products, introduced in Canada in 1998, researchers from McGill University and the University of Alberta report in the British Medical Journal.
  •  
    Increased intakes of folic acid by mandatory fortification of grain products to reduce neural tube defects may also reduce a baby's risk of severe congenital heart defects, says a new study. The incidence of the heart problems was reduced by 6 per cent following mandatory fortification of grain products, introduced in Canada in 1998, researchers from McGill University and the University of Alberta report in the British Medical Journal.
  •  
    For more similar articles reviewed, visit drjohndc.tumblr.com
Matti Narkia

Benfotiamine nothing but "Snake Oil" - 0 views

  •  
    A popular vitamin supplement is being advertised with claims that are demonstrably untrue, as revealed by research published in the open access journal BMC Pharmacology. Benfotiamine is a synthetic derivative of thiamine (vitamin B1). It is marketed heavily as a dietary supplement using a selection of unsubstantiated, 'not-quite-medical' claims that tend to characterize this field. A large part of this campaign has been built around the belief that benfotiamine is lipid-soluble and, therefore, more physiologically active. Scientific research led by Dr Lucien Bettendorff of the Center for Cellular and Molecular Neurobiology at the University of Liège, Belgium, has entirely disproved these claims.
Dr. John Bureau DC

Medical News: Heart Patients Should Walk Often, Walk Far - in Primary Care, Exercise & ... - 0 views

  • LITTLE FALLS, N.J., May 13 -- Exercise regimens that burn more calories over less-intense periods of exercise can increase weight loss and reduce cardiovascular risk factors better than standard cardiac rehabilitation programs, researchers have found. Action Points  Explain that walking more at a slower pace improved weight loss and cardiac risk factors better than standard cardiac rehabilitation programs.Note that current cardiac rehabilitation guidelines were written when deconditioning after lengthy hospital stays was common, which is no longer the case. In a randomized trial, overweight patients who exercised more but with less intensity lost twice as much weight as those on typical cardiac rehab regimens and had greater reductions in markers of metabolic syndrome, according to Philip A. Ades, M.D., of the University of Vermont, and colleagues. "High-calorie-expenditure exercise is superior to standard cardiac rehabilitation exercise in accomplishing weight loss and favorably altering cardiometabolic risk factors, particularly insulin resistance, in overweight patients with coronary heart disease," the researchers reported online in Circulation: Journal of the American Heart Association.
  •  
    LITTLE FALLS, N.J., May 13 -- Exercise regimens that burn more calories over less-intense periods of exercise can increase weight loss and reduce cardiovascular risk factors better than standard cardiac rehabilitation programs, researchers have found. In a randomized trial, overweight patients who exercised more but with less intensity lost twice as much weight as those on typical cardiac rehab regimens and had greater reductions in markers of metabolic syndrome, according to Philip A. Ades, M.D., of the University of Vermont, and colleagues. "High-calorie-expenditure exercise is superior to standard cardiac rehabilitation exercise in accomplishing weight loss and favorably altering cardiometabolic risk factors, particularly insulin resistance, in overweight patients with coronary heart disease," the researchers reported online in Circulation: Journal of the American Heart Association.
Matti Narkia

Climate 'biggest health threat' - BBC NEWS | Science & Environment - 0 views

  •  
    Climate change is "the biggest global health threat of the 21st Century", according to a leading medical journal. The Lancet, together with University College London researchers, has published a report outlining how public health services will need to adapt.
Matti Narkia

Stem Cells Buy Freedom From Insulin for Type 1 Diabetics - MedlinePlus - 0 views

  •  
    TUESDAY, April 14 (HealthDay News) -- A particular type of stem cell transplantation using the patient's own cells led to short-term freedom from insulin injections in 20 of 23 patients newly diagnosed with type 1 diabetes participating in an experimental protocol in Brazil. One patient even managed to go four years without needing outside sources of insulin, although the average was 31 months, said the authors of a report in the April 15 issue of the Journal of the American Medical Association, a themed issue on diabetes. The patients also kept their blood sugar under control, which is key to preventing complications from diabetes. And, the authors stated, increased C-peptide levels indicated that the pancreas' beta cells were alive and well.
Matti Narkia

Lipoprotein(a) Linked to Heart Attacks - 0 views

  •  
    June 9, 2009 -- Genetic testing confirms that high levels of a type of cholesterol known as lipoprotein(a) are associated with an increased risk for heart attacks, but the clinical implications of the finding are unclear. Lipoprotein(a) has long been suspected of contributing to cardiovascular risk. But this new research offers the strongest evidence yet identifying it as an independent risk factor for heart attack. The study appears in the June 10 issue of the Journal of the American Medical Association.
Dr. John Bureau DC

Medical News: AAN: Epilepsy Drug Not Effective for Chronic Headache - in Meeting Covera... - 0 views

  • SEATTLE, April 30 -- The epilepsy drug levetiracetam (Keppra) does not appear to be effective for prevention of chronic daily headache, researchers said here. Action Points  Explain that the epilepsy drug levetiracetam did not significantly increase the headache-free rate for patients with chronic daily headache compared with placebo.Note, however, that there was a significant reduction in disability and reduced pain severity in the treatment group, and the findings show that there is a subpopulation of chronic daily headache patients for whom levetiracetam remains a therapeutic option.Note that this study was published as an abstract and presented orally at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal. Levetiracetam drug achieved a 3.9% increase in headache-free performance over placebo, but the trend did not reach statistical significance, Roy Beran, M.D., of the University of New South Wales, and colleagues reported at the American Academy of Neurology meeting.
  •  
    SEATTLE, April 30 -- The epilepsy drug levetiracetam (Keppra) does not appear to be effective for prevention of chronic daily headache, researchers said here. Levetiracetam drug achieved a 3.9% increase in headache-free performance over placebo, but the trend did not reach statistical significance, Roy Beran, M.D., of the University of New South Wales, and colleagues reported at the American Academy of Neurology meeting.
1 - 14 of 14
Showing 20 items per page